|Place of Origin:||CHINA|
|Certification:||GMP , ISO 9001:2008|
|Model Number:||CAS: 137-58-6|
|Minimum Order Quantity:||100g|
|Packaging Details:||Stealth And Discreet Packaging|
|Delivery Time:||Within 7 Working Days|
|Payment Terms:||Bank Transfer - Bitcoin - Western Union - MoneyGram|
|Supply Ability:||2000 KG/Month|
local anesthesia drugs,
pure benzocaine powder
99.56% Superb Anesthetic Powder Lidocaine ( Lidocaine Base )
Product Name: Lidocaine
storage temp: Store at RT
solubility ethanol: 4 mg/mL
Water Solubility: practically insoluble
Stability: Stable. Incompatible with strong oxidizing agents.
Usage: Lidocaine is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of
Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic
drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations,
injected as a dental anesthetic, or as a local anesthetic for minor surgery.It is on the World Health
Organization's List of Essential Medicines, a list of the most important medications needed in a
basic healthcare system.
Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the
treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning,
cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated.
Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have
been initiated. A routine prophylactic administration is no longer recommended for acute cardiac
infarction; the overall benefit of this measure is not convincing.
Lidocaine crosses the blood-brain and placental barriers, presumably by passive diffusion.
Lidocaine is metabolized rapidly by the liver, and metabolites and unchanged drug are excreted
by the kidneys. Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage
of the amide linkage, and conjugation. N-dealkylation, a major pathway of biotransformation,
yields the metabolites monoethylglycinexylidide and glycinexylidide. The pharmacological /
toxicological actions of these metabolites are similar to, but less potent than, those of Lidocaine.
Approximately 90% of Lidocaine administered is excreted in the form of various metabolites, and
less than 10% is excreted unchanged.
Lab Test Result:
Any needs, please contact us